Skip to Content

Lido-Rx Cream

Generic Name: lidocaine, capsaicin
Dosage Form: cream

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

DESCRIPTION

  

Disclaimer: The FDA has not evaluated this drug, and FDA has not approved this labeling.

Lido-Rx 4.1 is a Lidocaine 4% and Capsaicin 0.1% cream which is a topical anesthetic and

analgesic indicated for the relief of pain related to minor cuts, grazes and irritation.

NOTE: There is no menthol in this product.

INDICATIONS AND USAGE

  

Lido-Rx 4.1 is a topical anesthetic and analgesic indicated for the relief of pain related to minor cuts,

grazes and irritations.

WARNINGS

  

For external use only.
Use only as directed.
Avoid contact with eyes and mucous membranes.
Do not cover with bandage.
Do not use on wounds or damaged skin.
Consult physician for children under 12.
Do not use if you are allergic to Capsaicin or Lidocaine
Stop use and ask a doctor if conditions worsen, symptoms persist for more than 7 days or clear up and occur

again within a few days or rash, itching or excessive skin irritation occurs.

KEEP OUT OF REACH OF CHILDREN.

Precautions

If irritation or sensitivity occurs or infection appears, discontinue use and institute appropriate therapy.

Lido-Rx 4.1 Cream should be used with caution in ill, elderly, debilitated patients and children who may

be more sensitive to the systemic effects of lidocaine.

Carcinogenesis, Mutagenesis, and Impairment of Fertility:

Studies of lidocaine in animals to evaluate the carcinogenic and mutagenic potential of the effect on fertility

have not been conducted.

USE IN PREGNANCY:

Teratogenic Effects; Pregnancy Category B.

Reproduction studies have been performed for lidocaine in rats at doses up to 6.6 times the human dose and

have revealed no evidence of harm to the fetus caused by lidocaine. There are, however, no adequate and

well-controlled studies in pregnant women. Animal reproduction studies are not always predictive of human

response. General consideration should be given to this fact before administering lidocaine to women of

childbearing potential, especially during early pregnancy when maximum organogenesis takes place.

NURSING MOTHERS:

Lidocaine is excreted in human milk. The clinical significance of this observation is unknown.

Caution should be exercised when lidocaine is administered to a nursing woman.

PEDIATRIC USE:

Dosage in pediatric patients should be reduced commensurate with age, body weight, and physical condition.

ADVERSE REACTIONS:

During or immediately after treatment, the skin at the site of treatment may develop erythema or edema or

may be the locus of abnormal sensation.

CALL YOUR DOCTOR ABOUT SIDE EFFECTS.

DOSAGE AND ADMINISTRATION

  

Instructions for Use

Clean and dry affected area
Apply directly to area of pain
Apply to affected area not more than 4 times daily
Wash hands with soap after applying.

Adults and children 12 years and over

apply to affected area not more than 4 times daily

Children under 12 years consult physician before use

Call your doctor about side effects. You may report side effects to the FDA at 1-800-FDA-1088

1-800-FDA-1088 FREE.

KEEP THIS AND ALL MEDICATIONS OUT OF REACH OF CHILDREN.

All prescriptions using this product shall be pursuant to state statutes as applicable. This is not an Orange

Book product. This product may be administered only under a physician's supervision.

There are no implied or explicit claims on the therapeutic equivalence.

Store at 25ºC (77ºF); excursions permitted to 15º-30ºC (59º-86º F). See USP Controlled Room Temperature.

Protect from freezing.

HOW SUPPLIED

  

Lido-Rx 4.1 is supplied in a single box with a 5, 30 or 60 gram tube inside the box.

Lido-Rx 4.1 Cream 60 gram tube NDC 70036-010-60

Lido-Rx 4.1 Cream 30 gram tube NDC 70036-010-30

Lido-Rx 4.1 Cream 30 gram tube NDC 70036-010-05

Storage: Store below 25°C. Avoid direct sunlight.

Distributed by:

Cloverleaf Pharma, LLC, Fl  32502

770-579-8883

Manufactured exclusively for Cloverleaf Pharma LLC, by:

Pocono Coated Products, LLC

Greensboro, N.C. USA 27407

Purified Water, Isopropyl Palmitate,  Propylene Glycol, Glyceryl Sterate, Isononyl Isonanoate, Glycerin, Lanolin Oil,

Myristyl Myristate, Stearic Acid, Carbmer, Methylparaben, Diazolidinyl Urea, Iodopropynyl Butylcarbamate,

Disodium EDTA, Allantoin, Triethanolamine, Sorbitan Sterate, Polysorbate, Dimethicone, Propylparaben,

BHA Tenox, Aloe Vera Gel, Vitamin A, Vitamin D, Tocopheryl Acetate

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

  

LIDO-RX   4.1
lidocaine 4.0% capsaicin 0.10% cream
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:70036-010
Route of Administration TOPICAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LIDOCAINE (LIDOCAINE) LIDOCAINE 4 g  in 30 g
CAPSAICIN (CAPSAICIN) CAPSAICIN 0.10 g  in 30 g
Inactive Ingredients
Ingredient Name Strength
WATER  
ISOPROPYL PALMITATE  
MYRISTYL MYRISTATE  
GLYCERIN  
POLYETHYLENE GLYCOLS  
LANOLIN OIL  
STEARIC ACID  
METHYLPARABEN  
DIAZOLIDINYL UREA  
IODOPROPYNYL BUTYLCARBAMATE  
DISODIUM EDTA-COPPER  
ALLANTOIN  
TRIETHANOLAMINE LACTATE  
POLYSORBATE 60  
DIMETHICONE  
PROPYLPARABEN  
VITAMIN A  
VITAMIN D  
Product Characteristics
Color white Score     
Shape Size
Flavor Imprint Code
Contains         
Packaging
# Item Code Package Description
1 NDC:70036-010-30 30 g in 1 TUBE
2 NDC:70036-010-05 5 g in 1 TUBE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
unapproved drug other 01/25/2016
Labeler - Cloverleaf Pharma LLC (079818984)
Registrant - Cloverleaf Pharma LLC (079818984)
Revised: 01/2016
 
Cloverleaf Pharma LLC



Hide